FDA Drug Recalls

Recalls / Class II

Class IID-0597-2024

Product

Nitrofurantoin Capsules, USP (Macrocrystals), 100 mg, Rx Only, 100 capsules per bottle, Manufactured by: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun - 248-197, Uttarakhand, India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-233-88.

Brand name
Nitrofurantion
Generic name
Nitrofurantion
Active ingredient
Nitrofurantoin
Route
Oral
NDCs
57664-231, 57664-232, 57664-233
FDA application
ANDA201722
Affected lot / code info
Lot #s: 231067, 231069, Exp 04/30/2025

Why it was recalled

Failed Dissolution Specifications

Recalling firm

Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Manufacturer
Sun Pharmaceutical Industries, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2 Independence Way, Princeton, New Jersey 08540-6620

Distribution

Quantity
5752 bottles
Distribution pattern
Nationwide in the USA and Puerto rico

Timeline

Recall initiated
2024-07-09
FDA classified
2024-07-12
Posted by FDA
2024-07-24
Terminated
2025-12-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0597-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.